Better resource allocation and targeted programs will be needed to help vulnerable hospitals combat the trend.

Experts hope the FAI score can become the next big tool in personalized risk assessment, though costs remain unknown.

In Part 2, Wayne Batchelor, Vinod Thourani, Megan Coylewright, Basel Ramlawi, Sammy Elmariah, and Tsuyoshi Kaneko discuss ...

In a pivot from personal safety measures, the multisociety effort calls on stakeholders to pursue a modern, standardized ...

More than half of US adults are eligible for primary prevention with statins, yet lipid-lowering therapies remain underused.

This month: online GLP-1 concerns, psychological impact of wearables, sexual and gender minority health insights, and more.

With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.

The US Food and Drug Administration has approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for reducing LDL ...

The FLASH protocol, associated with less radiation than a CAC scan, should be used more often in this cohort, a researcher ...

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

Results from the DAPT-MVD trial, while not necessarily generalizable, do open the door to a new tactic in select cases.

In addition to giving patients standard verbal breath-holding instructions, the segment offers them an idea of what to expect ...